Get startedLog in
    Picture of Matinas BioPharma Holdings logo

    MTNB — Matinas BioPharma Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Matinas BioPharma Reports Third Quarter 2021 Financial Results And Operational Highlights

    Picture of Matinas BioPharma Holdings logoMatinas BioPharma Holdings
    08/11/2021 11:38
    Nov 8 (Reuters) - Matinas BioPharma Holdings Inc  MTNB.A :
    * MATINAS BIOPHARMA REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
    * Q3 LOSS PER SHARE $0.03
    * BELIEVES CASH ON HAND IS SUFFICIENT TO FUND PLANNED
OPERATIONS
INTO 2024
    * Q3 EARNINGS PER SHARE VIEW $-0.02 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3R93xx 
Further company coverage:  MTNB.A 

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Matinas BioPharma Holdings

    See all news